Study of Gynecological Follow-up of Patients With Autoimmune Disease or Inflammatory Rheumatism
Conditions: Arthritis, Rheumatoid; Spondylitis, Ankylosing; Lupus Erythematosus, Systemic; Scleroderma, Systemic; Sjogren's Syndrome; Mixed Connective Tissue Disease Intervention: Behavioral: Questionnaire Sponsor: University Hospital, Bordeaux Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 27, 2023 Category: Research Source Type: clinical trials
Rituxmab Versus IL-6 in Treating ILD
Conditions: Interstitial Lung Disease; Scleroderma Interventions: Drug: Rituximab; Drug: IL6 inhibitor Sponsor: Assiut University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 27, 2023 Category: Research Source Type: clinical trials
Study of Gynecological Follow-up of Patients With Autoimmune Disease or Inflammatory Rheumatism
Conditions: Arthritis, Rheumatoid; Spondylitis, Ankylosing; Lupus Erythematosus, Systemic; Scleroderma, Systemic; Sjogren's Syndrome; Mixed Connective Tissue Disease Intervention: Behavioral: Questionnaire Sponsor: University Hospital, Bordeaux Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 27, 2023 Category: Research Source Type: clinical trials
Rituxmab Versus IL-6 in Treating ILD
Conditions: Interstitial Lung Disease; Scleroderma Interventions: Drug: Rituximab; Drug: IL6 inhibitor Sponsor: Assiut University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 27, 2023 Category: Research Source Type: clinical trials
Study of Gynecological Follow-up of Patients With Autoimmune Disease or Inflammatory Rheumatism
Conditions: Arthritis, Rheumatoid; Spondylitis, Ankylosing; Lupus Erythematosus, Systemic; Scleroderma, Systemic; Sjogren's Syndrome; Mixed Connective Tissue Disease Intervention: Behavioral: Questionnaire Sponsor: University Hospital, Bordeaux Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 27, 2023 Category: Research Source Type: clinical trials
Rituxmab Versus IL-6 in Treating ILD
Conditions: Interstitial Lung Disease; Scleroderma Interventions: Drug: Rituximab; Drug: IL6 inhibitor Sponsor: Assiut University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 27, 2023 Category: Research Source Type: clinical trials
Study of Gynecological Follow-up of Patients With Autoimmune Disease or Inflammatory Rheumatism
Conditions: Arthritis, Rheumatoid; Spondylitis, Ankylosing; Lupus Erythematosus, Systemic; Scleroderma, Systemic; Sjogren's Syndrome; Mixed Connective Tissue Disease Intervention: Behavioral: Questionnaire Sponsor: University Hospital, Bordeaux Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 27, 2023 Category: Research Source Type: clinical trials
Rituxmab Versus IL-6 in Treating ILD
Conditions: Interstitial Lung Disease; Scleroderma Interventions: Drug: Rituximab; Drug: IL6 inhibitor Sponsor: Assiut University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 27, 2023 Category: Research Source Type: clinical trials
Study of Gynecological Follow-up of Patients With Autoimmune Disease or Inflammatory Rheumatism
Conditions: Arthritis, Rheumatoid; Spondylitis, Ankylosing; Lupus Erythematosus, Systemic; Scleroderma, Systemic; Sjogren's Syndrome; Mixed Connective Tissue Disease Intervention: Behavioral: Questionnaire Sponsor: University Hospital, Bordeaux Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 27, 2023 Category: Research Source Type: clinical trials
Rituxmab Versus IL-6 in Treating ILD
Conditions: Interstitial Lung Disease; Scleroderma Interventions: Drug: Rituximab; Drug: IL6 inhibitor Sponsor: Assiut University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 27, 2023 Category: Research Source Type: clinical trials
Acceptance and Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) Vaccination in Systemic Sclerosis Patients Treated by Autologous Hematopoietic Stem Cell Transplantation
Conditions: Systemic Sclerosis; SARS-CoV 2 Vaccination Intervention: Sponsor: Assistance Publique - Hôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 25, 2023 Category: Research Source Type: clinical trials
